Skip to main content
. 2018 Oct 9;104(6):1062–1073. doi: 10.1002/cpt.1208

Figure 1.

Figure 1

Timeline for human immunodeficiency virus (HIV) vaccine efficacy trials. Years at the top are for 4‐year intervals, individual years are designated by dotted lines. Ad5, adenovirus serotype 5 vector; Ad26, adenovirus serotype 26 vector; ALVAC, canarypox vector; HVTN, HIV Vaccine Trials Network; IVDU, intravenous drug users; MSM, men who have sex with men; RSA, Republic of South Africa; TGSM, male to female transgender individuals who have sex with men; US, United States; VCP, canary pox vector.